STOCK TITAN

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) Financials

HAVAR NASDAQ
Trailing 12 months to September 30, 2026
Revenue Not reported for the trailing 12 months
Net Income $4.1M YoY not available
EPS (Diluted) Not reported for the trailing 12 months
Operating Cash Flow $734K n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HAVAR SEC filings page.

This page shows Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HAVAR FY2025

The reported balance sheet carries negative equity, while positive net income did not translate into operating cash.

Positive net income of $729K accompanied operating cash flow of -$1.31M, making the earnings figure a poor guide to cash generation in FY2025. The supplied cash-conversion measure was -179.9%, indicating that reported earnings and operating liquidity moved in opposite directions.

Total liabilities of $150.8M exceeded total assets of $147.1M, leaving negative equity of -$3.7M. This is a broad balance-sheet deficit even though short-term coverage looked better: current assets of $1.11M exceeded current liabilities of $474K, producing a 2.3x current ratio.

Cash flows show financing dependence around a major investment: investing cash flow was -$145.0M, while financing cash flow was $146.3M. Because operating cash flow was also negative, the reported cash movement was not generated by the business's routine operations but was closely associated with financing activity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to used $1.80 of operating cash (-$1.3M OCF vs $729K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
$1.1M
YoYn/m
QoQ+2.2%

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to reported $1.1M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 2.2%.

Revenue

Not reported for Q3 2026.

EBITDA

Not reported for Q3 2026.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$674K
YoY-63.9%
QoQ-12.6%

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to held $674K in cash as of Q3 2026; no long-term debt figure is on record for that period.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Shares Outstanding

Not reported for Q3 2026.

Margins & Returns

None of these metrics is reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

HAVAR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HAVAR quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Income-$285Kn/m-$248Kn/m-$162Kn/m-$177K-$33K-$42K-$22KN/A
Net Income$1.1Mn/m$1.1Mn/m$1.1Mn/m$826K-$33Kn/m-$42K-$22KN/A
EPS (Basic)N/AN/AN/AN/A-$0.01n/mN/AN/AN/A
EPS (Diluted)N/AN/AN/AN/A-$0.01n/mN/AN/AN/A
Diluted Shares (Avg)N/AN/AN/AN/A5M0.0%N/AN/AN/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax.

HAVAR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HAVAR quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$150.7M+6528.5%$149.5M$148.3M$147.1M+67750.9%$2.3MN/AN/A$217K
Current Assets$702K-62.8%$848K$993K$1.1M+11246.8%$1.9MN/AN/A$10K
Cash & Equivalents$674K-63.9%$771K$868K$965K+15770.4%$1.9MN/AN/A$6K
Short-Term Investments$0n/m$0$0$0n/m$0N/AN/A$0
Long-Term Investments$0n/m$0$0$0n/m$0N/AN/A$0
Total Liabilities$155.1M+6283.2%$153.6M$152.2M$150.8M+54441.1%$2.4MN/AN/A$277K
Current Liabilities$761K-68.7%$622K$520K$474K+71.4%$2.4MN/AN/A$277K
Non-Current Liabilities$154.3Mn/m$153.0M$151.7M$150.4Mn/m$0N/AN/A$0
Total Equity-$4.4Mn/m-$4.1Mn/m-$3.9Mn/m-$3.7Mn/m-$156K-2117.4%-$124K-$82K-$60K
Retained Earnings-$4.4Mn/m-$4.1M-$3.9M-$3.7Mn/m-$181KN/AN/A-$85K

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

HAVAR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HAVAR quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$50Kn/m$20Kn/m$8Kn/m$656Kn/m-$1.9Mn/m-$41K-$20K-$5K
Financing Cash Flow-$50K-102.6%-$20K-148.5%-$8K-141.4%$144.3M$1.9M$41K$20KN/A

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

HAVAR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HAVAR quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Return on Assets0.7%+2.1pp0.7%0.8%0.6%-1.4%N/AN/AN/A
Current Ratio0.92+0.1x1.361.912.34+2.3x0.78N/AN/A0.04

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$3.7M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Yes, Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) reported a net income of $4.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $729K.

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) recorded an outflow of $1.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) had $147.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) had a current ratio of 2.34 as of fiscal year 2025, which is generally considered healthy.

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) had a return on assets of 0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) held $965K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.3M over that year. Dividing the one by the other, the reported balance equals about 9 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) has negative shareholder equity of -$3.7M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

For every $1 of reported earnings, Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to (HAVAR) used $1.80 of operating cash (-$1.3M OCF vs $729K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top